Federal Judge Livid With Justice Lawyer Over CVS-Aetna Deal
“You need to slow this down,” U.S. District Judge Richard Leon in Washington said Thursday. “You're like a freight train out of control.” CVS and Aetna announced the completion of their merger on Wednesday, following the US Justice Department's approval in October.
November 29, 2018 at 02:20 PM
4 minute read
The original version of this story was published on National Law Journal
A federal judge excoriated a U.S. Justice Department lawyer Thursday for keeping him “in the dark” about the consummation of CVS Health's $69 billion acquisition of Aetna Inc. and urged the companies to wait for a final judgment on the deal before integrating their operations.
Washington U.S. District Judge Richard Leon, appearing livid at times, accused the Justice Department and the two companies of treating his antitrust review of the acquisition as a “rubber stamp operation.” And he expressed concern about how the integration of CVS and Aetna, which completed their merger Wednesday, would be unwound in the event that he rejects their merger.
“You need to slow this down,” Leon said. “You're like a freight train out of control.”
The Justice Department approved the deal in October on the condition that Aetna sell its Medicare Part D prescription drug plan business.
Leon had scheduled Thursday's hearing in response to the Justice Department's request to appoint Julie Myers Wood, chief executive of the the monitoring firm Guidepost Solutions, to oversee the insurance giant divestiture of that business to WellCare Health Plans Inc. After receiving the motion to appoint Myers as the monitor, Leon said he “kind of got this uneasy feeling about being kept in the dark, kind of like a mushroom.”
Leon asked Justice Department lawyer Jay Owen about the “practical consequences” of the merger. When Owen said CVS and Aetna had closed their deal, Leon sarcastically replied, “Thanks for telling me.”
Leon, who approved AT&T Inc.'s acquisition of Time Warner in June, stressed that he had not issued a final judgment approving the CVS-Aetna merger and noted that the public comment period on the Justice Department's settlement allowing the deal was not set to close until mid-December. The judge pointed to what he described as a “140-page” opposition filed by the American Medical Association, saying that he would take comments and other evidence into account before handing down a final ruling on the acquisition.
“Let's make it clear, Mr. Owen: This court's not a rubber stamp,” Leon said.
“Who knows where this is going. No one knows,” Leon said later in the hearing. “And you all are treating this like a rubber stamp operation.”
Owen declined to comment after the hearing.
Lawyers for CVS and Aetna were not called to speak during the hearing. CVS was represented in court Thursday by Dechert partner Rani Habash. Davis Polk & Wardwell partners Howard Shelanski and Jesse Solomon appeared for Aetna.
Leon suggested his ruling might not come for several months. He asked, “If I rule against it, how do you untangle seven months of integration?”
“Very difficult,” Leon said, answering his own question.
Owen described the possibility of the deal's rejection as a “business risk” that the companies were bearing.
Leon urged the Justice Department to meet with Aetna and CVS and consider how to account for the possibility of the merger being rejected, before scheduling a follow-up hearing for Dec. 3.
When Owens asked if Leon would still appoint Myers to oversee Aetna's divestiture, the judge said the companies also needed to consider what ramifications a denial of the merger would have for the insurer's planned sale of the prescription drug plan business to WellCare.
“You need to think about that, frankly,” Leon said. “See you Monday.”
|Read more:
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
NOT FOR REPRINT
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
You Might Like
View All'Substantive Deficiencies': Judge Grants Big Law Motion Dismissing Ivy League Price-Fixing Claims
3 minute readTrump, Harris Might Alter DOJ, FTC Enforcement in Counterintuitive Ways
5 minute readWould FTC Chair Lina Khan Stay on Under a President Harris or Trump?
6 minute readA Harris Administration Would Likely Review Merger Effects on Workers, Consumers, Antitrust Experts Say
4 minute readTrending Stories
Who Got The Work
Dechert partners Andrew J. Levander, Angela M. Liu and Neil A. Steiner have stepped in to defend Arbor Realty Trust and certain executives in a pending securities class action. The complaint, filed July 31 in New York Eastern District Court by Levi & Korsinsky, contends that the defendants concealed a 'toxic' mobile home portfolio, vastly overstated collateral in regards to the company's loans and failed to disclose an investigation of the company by the FBI. The case, assigned to U.S. District Judge Pamela K. Chen, is 1:24-cv-05347, Martin v. Arbor Realty Trust, Inc. et al.
Who Got The Work
Arthur G. Jakoby, Ryan Feeney and Maxim M.L. Nowak from Herrick Feinstein have stepped in to defend Charles Dilluvio and Seacor Capital in a pending securities lawsuit. The complaint, filed Sept. 30 in New York Southern District Court by the Securities and Exchange Commission, accuses the defendants of using consulting agreements, attorney opinion letters and other mechanisms to skirt regulations limiting stock sales by affiliate companies and allowing the defendants to unlawfully profit from sales of Enzolytics stock. The case, assigned to U.S. District Judge Andrew L. Carter Jr., is 1:24-cv-07362, Securities and Exchange Commission v. Zhabilov et al.
Who Got The Work
Clark Hill members Vincent Roskovensky and Kevin B. Watson have entered appearances for Architectural Steel and Associated Products in a pending environmental lawsuit. The complaint, filed Aug. 27 in Pennsylvania Eastern District Court by Brodsky & Smith on behalf of Hung Trinh, accuses the defendant of discharging polluted stormwater from its steel facility without a permit in violation of the Clean Water Act. The case, assigned to U.S. District Judge Gerald J. Pappert, is 2:24-cv-04490, Trinh v. Architectural Steel And Associated Products, Inc.
Who Got The Work
Michael R. Yellin of Cole Schotz has entered an appearance for S2 d/b/a the Shoe Surgeon, Dominic Chambrone a/k/a Dominic Ciambrone and other defendants in a pending trademark infringement lawsuit. The case, filed July 15 in New York Southern District Court by DLA Piper on behalf of Nike, seeks to enjoin Ciambrone and the other defendants in their attempts to build an 'entire multifaceted' retail empire through their unauthorized use of Nike’s trademark rights. The case, assigned to U.S. District Judge Naomi Reice Buchwald, is 1:24-cv-05307, Nike Inc. v. S2, Inc. et al.
Who Got The Work
Sullivan & Cromwell partner Adam S. Paris has entered an appearance for Orthofix Medical in a pending securities class action arising from a proposed acquisition of SeaSpine by Orthofix. The suit, filed Sept. 6 in California Southern District Court, by Girard Sharp and the Hall Firm, contends that the offering materials and related oral communications contained untrue statements of material fact. According to the complaint, the defendants made a series of misrepresentations about Orthofix’s disclosure controls and internal controls over financial reporting and ethical compliance. The case, assigned to U.S. District Judge Linda Lopez, is 3:24-cv-01593, O'Hara v. Orthofix Medical Inc. et al.
Featured Firms
Law Offices of Gary Martin Hays & Associates, P.C.
(470) 294-1674
Law Offices of Mark E. Salomone
(857) 444-6468
Smith & Hassler
(713) 739-1250